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RESEARCH ARTICLE
Summary. Different strategies have been developed to produce vaccines against Pasteurella multocida. The approach
described herein involves overexpression on the bacterial cell surface of Fur-regulated IROMPs (iron-regulated outer-mem-
brane proteins). Accordingly, the ability of fur mutants to promote heterologous protection was examined in a Swiss mouse
animal model. Two fur mutants derived from P. multocida were isolated, one of which was also defective in the OmpH pro-
tein. In mice challenged with virulent P. multocida, outer-membrane protein (OMP) extracts of fur cells conferred the same
protection as obtained with wild-type cells grown in iron-depleted medium. Total protection was achieved with 40 μg of OMP
extract from the fur ompH mutant. Mice administered heat-inactivated fur ompH cells were 60% cross-protected. The pres-
ence of a galE mutation in these cells did not further increase the protection level. Additionally, cell disruption by sonication
provoked a higher level of protection than conferred by heat-treated cells. Taken together, the results showed that P. multoci-
da fur ompH cells offer a simple and suitable approach for cross-protecting animals against infection with P. multocida. [Int
Microbiol 2008; 11(1):17-24]
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Introduction
Iron is a critical element required by almost all living cells.
The outer-membrane proteins (OMPs) synthesized by many
gram-negative bacterial pathogens, such as Haemophilus
influenzae and Neisseria meningitidis, bind iron-binding
molecules, including transferrin, lactoferrin, hemoglobin,
heme, and ferritin, present in the blood and mucosa of their
host organisms [1,30]. The expression of nearly all of these
OMPs is under the control of the Fur (ferric uptake regulator)
protein [34], which binds iron in the cytoplasm of bacterial
cells. In this reaction, Fur forms a complex with Fe(II) and
then binds to a specific sequence, known as the Fur box
[3,16,17], in the promoter region of iron-regulated genes,
thereby blocking their transcription. Many iron-regulated
outer-membrane proteins (IROMPs) are powerful antigens
as well as essential virulence factors during the infection
process of numerous pathogens [30]. For this reason, protec-
tion against these pathogens may be conferred either by vac-
cines based on the purified IROMP receptor [13] or by anti-
IROMP antisera [33]. 
Pasteurella multocida is a gram-negative bacterial
pathogen that causes several infectious diseases, including
fowl cholera, bovine pneumonia, hemorrhagic septicemia,
and swine atrophic rhinitis, in animals used in the production
of food. In veterinary medicine, a vaccine against P. multoci-
da, mainly based on inactivated P. multocida cells, known as
bacterins, or on live attenuated bacteria is available; however,
bacterins only confer homologous protection. Although cur-
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rent live vaccines promote heterologous and homologous
protection, they carry unknown attenuation markers and, in
some cases, have even been associated with disease out-
breaks [28]. Homologous protection has been obtained using
OMPs from P. multocida grown without iron deprivation [4].
In addition, several well-defined live attenuated and thy
mutant strains that are promising vaccine candidates have
been recently described [5,14,21]. 
Cross-protection has been achieved with bacterins [19] as
well as with OMP extracts [2,31] from P. multocida grown in
iron-depleted medium. The basis of this heterologous protec-
tion seems to be the overexpression of P. multocida IROMPs,
induced by the non-availability of iron in the environment
and, consequently, inside the cells [Kennett et al. 1993.
ACIAR Proceedings no. 43, pp 144-148]. However, bacteria
grow very poorly in the presence of divalent-cation chelators,
such as 2,2′-dipyridyl (DPD), which is an important limita-
tion for obtaining vaccines in large quantities [26].
Two hemoglobin-binding receptors of P. multocida were
initially characterized [7,15], and it was subsequently shown
that this bacterium has at least six other hemin- and/or hemo-
globin-binding proteins, all of which are immunogenic
[8,29]. Nonetheless, when inoculated individually, none of
these proteins conferred protection against heterologous
challenge [7,8; and B. Adler, personal communication]. The
recent isolation of the P. multocida fur gene has allowed us to
construct fur mutants of P. multocida [9]. Given that Fur reg-
ulates many bacterial iron-uptake proteins, such as hemin-
and/or hemoglobin-binding proteins, we postulated that over-
expression of IROMPs by P. multocida fur mutants would
mimic the response of P. multocida wild-type cells grown in
iron-depleted medium. Therefore, the aim of the present
study was to examine heterologous protection conferred by
P. multocida fur cells.
Materials and methods
Bacterial strains, plasmids and growth conditions. Bacterial
strains and plasmids used in this work are listed in Table 1. All P. multocida
strains were grown in liquid medium, either in buffered peptone water
(BPW, Merck, Darmstadt, Germany) or brain-heart infusion (BHI, Oxoid,
Madrid, Spain), and on sheep-blood agar (SBA, Biomérieux, Madrid, Spain)
or BHI plates. When necessary, antibiotics were added at the stated concen-
trations [11]. The concentration of the divalent-cation chelator DPD (Sigma,
Madrid, Spain) used in the experiments was 150 μM. 
Genetic methods. The P. multocida insertional fur mutant was
obtained from plasmid pUA891, which also contains a gene encoding resist-
ance to streptomycin. Plasmid pUA1089 was used to construct the double-
mutant fur galE. pUA1089 is a derivative of pKO3, a gene-replacement vec-
tor containing a temperature-sensitive replication protein [23], and harbors
the 2-kb mob region of plasmid pUA826. This region was isolated by restric-
tion of pUA826 with BamHI and then cloned into the BamHI site of pKO3.
P. multocida mutants were obtained by triparental mating, using pRK2013
as the mobilizing plasmid, as reported [11].
To determine the stability of the fur mutation, fur mutants were consec-
utively passaged 20 times on SBA plates in the absence of antibiotics. The
concentration of viable bacteria was determined at 5, 15, and 20 passages by
plating adequate dilutions of a cell suspension (109 colony-forming units,
CFU/ml) on SBA plates with and without streptomycin. Percent stability
was calculated as the number of colonies obtained on plates supplemented
with antibiotic relative to the number on plates without antibiotic.
Accordingly, the fur mutation was found to be maintained at 100% stability
in cells after 20 passages in the absence of selective pressure (data not
shown).
Biochemical methods, DNA and RNA techniques. DNA pro-
cedures and computerized sequence analysis were carried out as previously
described [11]. Nucleotide sequences were determined by the dideoxy
method on an ALF Sequencer (Pharmacia Biotech, Cerdanyola del Valles,
Barcelona). Total RNA extraction and reverse transcriptase PCR (RT-PCR)
analysis were done as reported [6]. In all cases, the absence of DNA in RNA
samples was tested by PCR without the addition of reverse transcriptase.
OMPs from P. multocida were extracted and analyzed as previously report-
ed [9]. Protein concentration was measured as described [24].
Protection studies against P. multocida. Groups of five 3-week-old
female Swiss mice (Harlan Ibérica, Barcelona, Spain) were intraperitoneal-
ly injected with 10 or 40 μg OMP extract/animal. The extracts were prepared
from several P. multocida strains grown under different culture conditions.
In all cases, the inoculated volume of extract was 100 μl and was given in
two doses 2 weeks apart. Control mice were inoculated with 100 μl of phos-
phate-buffered saline (PBS). Heterologous challenge was carried out 3
weeks later by intraperitoneal inoculation with a virulent strain of P. multo-
cida (PM1002). 
The same methodology was used to study protection conferred by heat
inactivation or sonication disruption of P. multocida strains PM1094 and
PM1096. Thermal inactivation was achieved by overnight incubation at
45°C of a culture previously grown in BHI at 30°C until a density of 7 × 108
CFU/ml was reached. Sonication-disrupted cells were prepared as follows:
The cells (7 × 108 CFU/ml) were resuspended in BPW, placed in an ice bath,
and then sonicated five times for 5 min at 80% duty cycle with an output of
40 W by using a Braun LabsonicU (Braun Biotech, Bethlehem, PA). The
absence of viable cells was tested by plating on SBA plates. In all cases, the
inoculated volume of extracts from inactivated cells was 100 μl, given as
two doses 2 weeks apart. Negative control and heterologous challenge were
done as described before. 
Results and Discussion
Construction of a P. multocida fur mutant. A
394-bp internal fragment of the P. multocida fur gene was
obtained by PCR amplification with Fur1 and Fur2 oligonu-
cleotide primers. This fragment was cloned into the suicide
plasmid pUA826, yielding plasmid pUA891. After introduc-
tion of pUA891 into P. multocida by triparental mating, sev-
eral putative fur mutants were isolated after plating the bac-
teria onto suitable selective plates. PCR analysis of the bac-
terial chromosomal DNA confirmed that the wild-type fur
gene had been interrupted by integration of pUA891 in two
clones (Fig. 1). The electrophoretic profiles of the outer-
membrane fractions of these two fur mutants were subse-
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quently analyzed to corroborate that the presence of the fur
mutation resulted in the induction of IROMPs of high molec-
ular mass, as previously described [9,18]. These two mutants
showed two different profiles (Fig. 2); the first mutant
expressed the major 36-kDa OMP of P. multocida, OmpH
[25], whereas, surprisingly, the second did not. Moreover, as
previously described [35], the absence of the major OMP
gave rise to outer-membrane reorganization with several
changes in the OMP profile (Fig. 2). Furthermore, the first
mutant grew more slowly than the parental strain. In light of
these different results, both fur mutants were retained for fur-
ther protection studies. 
In the complete genome sequence of P. multocida Pm70
[27], two copies of the ompH gene (separated by 154 bp),
encoding the proteins OmpH1 and OmpH2, have been iden-
tified. In order to ascertain the nature of the mutation respon-
sible for the OmpH– phenotype observed in strain PM1094,
RT-PCR analysis was carried out to determine whether the
ompH genes were transcribed. The results showed that
ompH1 and ompH2 were indeed independently transcribed
(Fig. 3); however, DNA sequencing of these genes (GenBank
accession nos. EF102481 and EF102482, respectively)
revealed significant differences compared to the correspon-
ding sequences in strains PM1011 and Pm70. In ompH1, a
nonsense mutation was found at position 76, resulting in a
stop codon instead of one that encodes glutamine; this gives
rise to a highly truncated protein of 24 amino acids.
Similarly, the ompH2 sequence of PM1094 strain had many
nucleotide changes, including a nonsense mutation at posi-
tion 670 that resulted in a truncated protein of 223 instead of
350 amino acids. These results clearly indicated that the
absence of the major 36-kDa OMP in the PM1094 mutant is
due to nonsense mutations in ompH1 and ompH2. It is known
that fur mutants have a high spontaneous mutagenesis rate
P. MULTOCIDA HETEROLOGOUS PROTECTION
Table 1. Bacterial strains and plasmids used in this work
Organism and plasmid Relevant features Source or reference
Escherichia coli 
DH5α F′/supE4 ΔlacU169 (Ø80 lacZΔM15) Clontech
hsdR17 recA1 endA1 gyrA96 thi-1 relA1
MC1061(λpir) hsdR mcrB araD139 Δ(araABC-leu)7679 ΔlacX74 Our laboratory
gal1 galK rpsL thi lysogenized with lpir bacteriophage
Pasteurella multocida
PM25 Wild-type, serogroup D Isolated from a rabbit nasal secretion
PM108 Wild-type, serogroup A Isolated from an ovine pneumonia outbreak
PM1002 PM25 RifR SpcR Our laboratory
PM1011 PM108 RifR SpcR Our laboratory
PM1094 PM1011 fur ompH This work
PM1095 PM1011 fur This work
PM1096 PM1094 galE This work
Plasmid
pGEM-T PCR cloning vector ApR Promega
pRK2013 rep (colE1) Mob+ Tra+ KmR Gary Ditta
pKO3 M13ori repA(ts) sacB CmR [23]
pUA826 Mob+ R6K replicon ApR StrR SpcR Our laboratory
pUA1089 pKO3 containing the mob site from pUA826 This work
pUA891 pUA826 carrying a 394-bp internal fragment of the P. multocida fur gene [9]
pUA1090 pUA1089 carrying a 495-bp internal fragment of the P. multocida galE gene This work
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Fig. 1. PCR analysis of Pasteurella
multocida fur mutants. (A) P. multo-
cida fur mutant construction. Fur3
and Aad3 indicate the positions of
oligonucleotide primers used to con-
firm the presence of the fur muta-
tion. (B) Chromosomal DNA from
wild-type strain (PM1011) (lane2),
fur (PM1095) (lane 3), and fur
ompH (PM1094) (lane 4) mutants
was subjected to PCR analysis with
the Aad3 and Fur3 oligonucleotide
primers. The PCR control lacking
DNA is shown in lane 5. HinfI-
digested Φ174 was used as a molec-
ular size marker (lanes 1 and 6).
Fig. 2. SDS-PAGE (12%) profile of OMPs from Pasteurella multocida
wild-type strain (PM1011) (lane 2), wild-type strain (PM1011) grown in
the presence of DPD (lane 3), fur (PM1095) (lane 4), and fur ompH
(PM1094) (lane 5). White arrow shows the high-molecular-mass proteins
induced in the presence of DP or in fur mutants. Broad Range markers and
Rainbow are shown in lanes 1 and 6, respectively. 
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because of the high oxidative stress imposed by the increased
iron uptake [10,32]. This fact likely explains the high num-
ber of base-pair changes found in ompH1 and ompH2. 
Protection studies with P. multocida fur
mutants. To analyze the putative protective effect of both
P. multocida fur mutants, mice were immunized with 10 and
40 μg of OMP extracts prepared from P. multocida wild-type
strain (PM1011) grown in the absence or presence of DPD,
and from both PM1094 and PM1095 mutants. The mice were
then heterologously challenged with the virulent strain
PM1002 (LD50 = 3 CFU/animal) at a dose of 500× LD50. All
mice immunized with the OMP extract obtained from wild-
type cells grown in the absence of DPD died 2 days after
challenge (Table 2). However, in support of our initial
hypothesis, equal protection (20%) was conferred in mice
immunized with 40 μg of OMP extract from the wild-type
strain grown under iron-depleted conditions vs. the same
amount of extract from the fur mutant (PM1095) (Table 2).
Remarkably, the OMP extract of the fur ompH mutant con-
ferred total protection (Table 2). Several studies have report-
ed that antibodies to some bacterial antigens may be detri-
mental to host defenses [20]. For instance, the deleterious
effect of vaccination with the highly immunogenic protein
PalA of Actinobacillus pleuropneumoniae was reported [36].
However, it was recently reported that purified OmpH protein
confers homologous protection in P. multocida [22]; thus, the
presence of OmpH does not seem to negatively affect host
defenses. The high level of protection obtained with the OMP
extract of the fur ompH mutant has at least two possible expla-
nations: (i) an increase of the relative concentration of
IROMPs in the extract due to the lack of the major OMP, and
(ii) the exposure of a new antigen and/or an increase in the
concentration of a particular antigen due to OMP outer-mem-
brane reorganization, as occurred in the fur ompH mutant. 
Since the highest level of protection was obtained with
the OMP extract prepared from the double-mutant fur ompH,
the next set of experiments was addressed at analyzing
whether heat-inactivated cells of the fur ompH mutant pro-
moted heterologous protection. The results showed that mice
administered heat-inactivated fur ompH cells and then het-
erologously challenged with strain PM1002 at a dose of 100×
LD50 were 60% protected (Table 3). An earlier study showed
that vaccination with killed bacteria generally results in
serotype-specific immunity [12], whereas heterologous pro-
tection is conferred only with attenuated strains [2]. By con-
trast, in this work, heterologous protection was obtained
using inactivated cells. These data indicated that simple heat
inactivation of fur ompH P. multocida cells can be used to
produce a vaccine conferring heterologous protection.
P. MULTOCIDA HETEROLOGOUS PROTECTION
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Fig. 3. Structural arrangement of Pasteurella multocida ompH1 and ompH2 genes. RTompH1up, RTompH1rp, RTompH2up, and RTompH2rp indicate the
positions of oligonucleotide primers used for transcriptional analysis (A). RT-PCR analysis of transcripts of the ompH1 (B), ompH2 (C) genes, and the pos-
sible operon ompH1-ompH2 (D) in either the wild-type strain (PM1011) (lanes 2) or the fur ompH mutant (PM1094) (lanes 3). Total RNA from each strain
and the oligonucleotide primer pairs RTompH1up and RTompH1rp (B), RTompH2up and RTompH2rp (C) and RTompH1up and RTompH2rp (D), were used.
PCRs with DNA from the wild-type strain (lanes 4) and from a negative control lacking both RNA and DNA (lanes 5) are shown.  Φ174 HinfI-digested (B, C)
and BstEII-digested- λ DNA (D) were used as molecular size markers (lanes 1). 
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To determine whether the protection level could be
increased by optimizing the surface exposure of antigens, a
rough derivate mutant of the fur ompH mutant was obtained.
The galE gene product catalyzes the epimerization of UDP-
galactose to UDP-glucose and is required for the correct syn-
thesis of the LPS core. A galE mutant is able to grow on glu-
cose but unable to synthesize wild-type cell-surface LPS,
thus yielding rough derivate cells. The galE mutant of the fur
ompH strain (PM1094) was constructed as follows. PCR
amplification with suitable oligonucleotide primers yielded a
495-bp internal fragment of galE. This fragment was then
cloned into pUA1089 and the plasmid was introduced into
strain PM1094 by triparental mating. Several putative galE
mutants were generated by plating onto suitable selective
plates. PCR analysis of the chromosomal DNA from four of
the transconjugants confirmed that insertion of pUA1090
interrupted the wild-type galE gene. One of these clones,
PM1096, was chosen for further study and analysis of its
OMP profile corroborated that it had the same profile as the
parental strain (data not shown). Mice were administered
heat-inactivated (45ºC for 12 h) fur ompH galE mutant cells
and then heterologously challenged with PM1002 at doses of
100 and 500× LD50. As seen in Table 3, those animals immu-
nized with the heat-inactivated strain were 60% protected at
Table 3. Protection conferred in mice challenged with heterologous Pasteurella multocida strain PM1002 follow-
ing immunization with inactivated strains of the bacterium 
Strain Inactivation procedurea Challenge dose  (× LD50) Survival
Wild-type H 500 0/5
H 100 0/5
fur ompH H 500 0/5
H 100 3/5
fur ompH galE H 500 0/5
H 100 3/5
Wild-type S 500 0/5
fur ompH galE S 500 3/5
PBSb 100 0/5
aCells were heat-inactivated by incubation at 45ºC for 12 h (H), or disrupted by sonication (S), as described in
Materials and methods. bPhosphate-buffered saline.
Table 2. Protection conferred in mice challenged with heterologous Pasteurella multocida PM1002 (500× LD50)
following immunization with OMPs of different strains of the bacterium
Strain source of OMP Relevant characteristics Doseb (μg/animal) Survival
PM1011 Wild-type 10 0/5
40 0/5
PM1011 Wild-type grown in the presence of DPDa 10 0/5
40 1/5
PM1095 fur 10 0/5
40 1/5
PM1094 fur ompH 10 4/5
40 5/5
PBSc 0/5
aThe divalent-cation chelator 2,2′-dipyridyl. bQuantity of OMP extract inoculated per animal immunization.
cPhosphate-buffered saline.
23INT. MICROBIOL. Vol.11, 2008
the lower challenge dose. Thus, although the bacterial cells
expressed a shorter cell-surface LPS, this did not result in
increased protection because heat-inactivated fur ompH and
fur ompH galE mutants induced the same level of protection
in immunized mice.
A different inactivation strategy based on cell disruption
by sonication was also tested. Mice immunized with sonica-
tion-disrupted fur ompH galE cells were found to be 60%
protected at the highest challenge dose (500× LD50) (Table 3).
Thus, cell disruption by sonication yielded a much better vac-
cine than obtained following heat-inactivation of the cells.
This may be due to the heat lability of the immunogenic pro-
teins. 
In conclusion, our results suggest that fur mutants can be
used to develop IROMP-based vaccines, particularly against
pathogens presenting multiple and different iron receptors, as
is the case with P. multocida. Furthermore, the strategy of
using fur mutants overcomes problems associated with other
methodologies, such as the poor growth of bacterial cells in
the presence of divalent-cation chelators. Moreover, the
absence of the OmpH protein significantly increased the
cross-protection conferred by the fur mutant of P. multocida.
These findings will contribute to the development of effec-
tive vaccines that protect against P. multocida infection.
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